growth?, page-13

unresolved future earnings growth problem continues to weigh in on share price. lack of update on this issue likely to be unsettling investors and buy interest. Medicare statistics for surgery procedures for first half 14 are actually reasonably good. little faith exists in PRY takeover, a plaything for them that is a distraction to VEI and unhelpful at best. management appears to have not delivered on initial expectations since banking $27m and diluting shares on issue over 1 year ago. talk of earnings diversification etc have remained just that. day traders have hopped in and back out over last 24 months as recovery story was running its course, now history. dividend update won't be released at least until Jun 14. confidence on delivering over long term can only be boosted by execution, nothing else really matters. new shareholders right to be displeased. old shareholders have seen it all before.